Mainz Biomed BV (MYNZ) — Financial Flexibility Index
Mainz Biomed BV (MYNZ) has a Financial Flexibility Index of -0.95x as of December 2025. Free cash flow of $-4.46 Million (operating CF $-4.46 Million minus capex $93.00) represents -1% of total liabilities ($4.69 Million). Check Mainz Biomed BV tangible book value ratio to evaluate the tangible quality of the company's equity base.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
Mainz Biomed BV Financial Flexibility Index (2019–2025)
Historical Financial Flexibility Index trend for Mainz Biomed BV across 7 annual periods. For the full cash flow conversion analysis, see Mainz Biomed BV (MYNZ) cash flow conversion.
Annual Financial Flexibility Index for Mainz Biomed BV (2019–2025)
Year-by-year free cash flow to debt coverage for Mainz Biomed BV. Explore MYNZ debt coverage from operations to assess how comfortably operating cash covers total debt obligations.
| Year | Flexibility Index | Free Cash Flow (USD) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2025 | -2.34x | $-10.98 Million | $-10.98 Million | $4.69 Million | ▼ -0.1% |
| 2024 | -2.34x | $-16.84 Million | $-17.09 Million | $7.19 Million | ▼ -42.0% |
| 2023 | -1.65x | $-20.04 Million | $-21.94 Million | $12.16 Million | ▲ +28.2% |
| 2022 | -2.30x | $-14.11 Million | $-14.77 Million | $6.14 Million | ▼ -163.8% |
| 2021 | -0.87x | $-3.20 Million | $-3.22 Million | $3.68 Million | ▼ -547.7% |
| 2020 | -0.13x | $-459.05K | $-468.74K | $3.41 Million | ▲ +11.9% |
| 2019 | -0.15x | $-406.81K | $-416.50K | $2.67 Million | — |